NCT05936177

Brief Osteoporosis Education to Increase Awareness in Middle Aged and Elderly.

Name: Clinical Trial NCT05936177
Creator: Selkin Yılmaz Muluk
Keywords: Osteoporosis, Patient education, other, clinical trial, Turkey

Effects of 20 Minutes Osteoporosis Education on the Awareness of Osteoporosis in People Registered in Elderly Care Homes

Selkin Yılmaz Muluk·ClinicalTrials.gov·otherRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Osteoporosis
Drug/Device/Intervention: Patient education
Study type: Interventional
Intervention type: other

Sponsor & location

Primary sponsor: Selkin Yılmaz Muluk
Funder: Antalya Training and Research Hospital
Location: Antalya, Turkey

Timeline & enrollment

Phase: N/A
Start date: Jun 08, 2023
End date: Oct 29, 2023
Enrollment: 150 participants

Primary outcome

Change in participants' knowledge about osteoporosis.

Summary

Osteoporosis is a growing global concern, particularly as the population of middle-aged and elderly individuals continues to rise within communities. This demographic, being more susceptible to chronic diseases, poses a burden on healthcare systems. The objective of this study is to explore methods of educating middle-aged and elderly individuals about osteoporosis, aiming to raise awareness of the disease and promote informed decision-making regarding prevention and treatment options

ICD-10 classifications

Osteoporosis, unspecifiedOther osteoporosisIdiopathic osteoporosisOsteoporosis in diseases classified elsewherePostmenopausal osteoporosis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05936177
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05936177 through Pure Global AI's free database. This phase not specified trial is sponsored by Selkin Yılmaz Muluk and is currently Recruiting. The study focuses on Osteoporosis. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.